Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased Donor.
Kamar N, Bertrand D, Caillard S, Pievani D, Apithy MJ, Congy-Jolivet N, Chauveau B, Farce F, François A, Delas A, Olagne J, Usureau C, Taupin JL, Guidicelli GL, Couzi L. Kamar N, et al. Among authors: delas a. Kidney Int Rep. 2024 Jul 30;9(10):2927-2936. doi: 10.1016/j.ekir.2024.07.024. eCollection 2024 Oct. Kidney Int Rep. 2024. PMID: 39430184 Free PMC article.
Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.
Del Bello A, Divard G, Belliere J, Congy-Jolivet N, Lanfranco L, Ricard R, Delas A, Colombat M, Esposito L, Hebral AL, Cointault O, Lefaucheur C, Loupy A, Kamar N. Del Bello A, et al. Among authors: delas a. Clin Transplant. 2019 Oct;33(10):e13681. doi: 10.1111/ctr.13681. Epub 2019 Sep 8. Clin Transplant. 2019. PMID: 31369170
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?
Massat M, Congy-Jolivet N, Hebral AL, Esposito L, Marion O, Delas A, Colombat M, Faguer S, Kamar N, Del Bello A; Toulouse Acquired Immune Deficiency, Infection (TAIDI) Study Group. Massat M, et al. Among authors: delas a. Am J Transplant. 2021 Apr;21(4):1641-1649. doi: 10.1111/ajt.16391. Epub 2020 Dec 13. Am J Transplant. 2021. PMID: 33141487 Free article.
Cytokine storm induced by a PD1 inhibitor in a renal transplant patient.
Del Bello A, Zakaroff AG, Meyer N, Delas A, Faguer S, Kamar N, Belliere J. Del Bello A, et al. Among authors: delas a. Am J Transplant. 2021 Jul;21(7):2616-2618. doi: 10.1111/ajt.16589. Epub 2021 Jun 22. Am J Transplant. 2021. PMID: 33797848 Free article. No abstract available.
41 results